| Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras JO McNamara, ER Andrechek, Y Wang, KD Viles, RE Rempel, E Gilboa, ... Nature biotechnology 24 (8), 1005-1015, 2006 | 1316 | 2006 |
| The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting RD Cardiff, MR Anver, BA Gusterson, L Hennighausen, RA Jensen, ... Oncogene 19 (8), 968-988, 2000 | 571 | 2000 |
| Anchorage-independent cell growth signature identifies tumors with metastatic potential S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ... Oncogene 28 (31), 2796-2805, 2009 | 388 | 2009 |
| Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis ER Andrechek, WR Hardy, PM Siegel, MA Rudnicki, RD Cardiff, ... Proceedings of the National Academy of Sciences 97 (7), 3444-3449, 2000 | 319 | 2000 |
| Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation SY Lunt, V Muralidhar, AM Hosios, WJ Israelsen, DY Gui, L Newhouse, ... Molecular cell 57 (1), 95-107, 2015 | 245 | 2015 |
| NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors X Zhou, D Hollern, J Liao, E Andrechek, H Wang Cell death & disease 4 (3), e560-e560, 2013 | 229 | 2013 |
| Triple-negative breast cancer and the potential for targeted therapy JR Jhan, ER Andrechek Pharmacogenomics 18 (17), 1595-1609, 2017 | 225 | 2017 |
| ErbB2 is required for muscle spindle and myoblast cell survival ER Andrechek, WR Hardy, AA Girgis-Gabardo, RLS Perry, R Butler, ... Molecular and cellular biology 22 (13), 4714-4722, 2002 | 154 | 2002 |
| The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer DP Hollern, J Honeysett, RD Cardiff, ER Andrechek Molecular and cellular biology 34 (17), 3229-3243, 2014 | 126 | 2014 |
| Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu C Montagna, ER Andrechek, H Padilla-Nash, WJ Muller, T Ried Oncogene 21 (6), 890-898, 2002 | 114 | 2002 |
| Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth ER Andrechek, D White, WJ Muller Oncogene 24 (5), 932-937, 2005 | 99 | 2005 |
| Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness LD Miller, JA Chou, MA Black, C Print, J Chifman, A Alistar, T Putti, X Zhou, ... Cancer immunology research 4 (7), 600-610, 2016 | 98 | 2016 |
| Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential ER Andrechek, RD Cardiff, JT Chang, ML Gatza, CR Acharya, A Potti, ... Proceedings of the National Academy of Sciences 106 (38), 16387-16392, 2009 | 97 | 2009 |
| Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data K Liu, PA Newbury, BS Glicksberg, WZD Zeng, S Paithankar, ... Nature communications 10 (1), 2138, 2019 | 91 | 2019 |
| Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers ER Andrechek, MA Laing, AA Girgis-Gabardo, PM Siegel, RD Cardiff, ... Cancer research 63 (16), 4920-4926, 2003 | 91 | 2003 |
| A genomic analysis of mouse models of breast cancer reveals molecular features ofmouse models and relationships to human breast cancer DP Hollern, ER Andrechek Breast Cancer Research 16, 1-16, 2014 | 90 | 2014 |
| Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer ER Andrechek, WJ Muller Breast Cancer Research 2, 1-6, 2000 | 83 | 2000 |
| The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment J Turpin, C Ling, EJ Crosby, ZC Hartman, AM Simond, LA Chodosh, ... Oncogene 35 (47), 6053-6064, 2016 | 77 | 2016 |
| Patterns of cell signaling pathway activation that characterize mammary development ER Andrechek, S Mori, RE Rempel, JT Chang, JR Nevins Oxford University Press for The Company of Biologists Limited 135 (14), 2403 …, 2008 | 70 | 2008 |
| E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration DP Hollern, MR Swiatnicki, JP Rennhack, SA Misek, BC Matson, ... Scientific reports 9 (1), 10718, 2019 | 69 | 2019 |
William J. MullerProfessor, McGill UniversityVerified email at mcgill.ca
